Teprotumumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Teprotumumab Usage And Synthesis

Uses

Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research[1].

References

[1] Chen H, et al. Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab. 2014 Sep;99(9):E1635-40. DOI:10.1210/jc.2014-1580

Teprotumumab(1036734-93-6)Related Product Information

• Enavatuzumab
• Raxibacumab
• Tilvestamab
• Alemtuzumab
• Lodelcizumab
• Oleclumab
• palivizumab
• Research Grade Lifastuzumab(DHB65401)
• Racotumomab
• Landogrozumab